Vasopressin Market to surpass US$ 2,912.0 million by 2028, Says Coherent Market Insights (CMI)

SEATTLE, Sept. 27, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global vasopressin market is estimated to be valued at US$ 1,112.6 million in 2021 and is expected to exhibit a CAGR of 14.7% during the forecast period (2021-2028).

Key Trends and Analysis of the Global Vasopressin Market:

The global vasopressin market is expected to witness significant growth, owing to increasing number of cardiovascular surgeries. For instance, according to the Centers for Disease Control and Prevention (CDC), every year about 340,000 coronary artery bypass grafting (CABG) procedures are performed in the U.S. Hence, increasing number of cardiovascular surgeries propels demand for vasopressin to control the blood flow.

Moreover, increasing approvals of vasopressin drug is expected to drive growth of the global vasopressin market. For instance, in April 2018, Eagle Pharmaceuticals, Inc announced the approval of its abbreviated new drug application (ANDA) for its 1ml vasopressin injection. The product is an original generic version of Endo International plc’s Vasostrict formulation.

Request for Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4646
Key Market Takeaways:

The global vasopressin market is expected to exhibit a CAGR of 14.7% during the forecast period (2021-2028), owing to increasing launches of vasopressin drug. For instance, in 2020, Dr Reddy's Laboratories, a pharmaceutical company launched desmopressin acetate injection USP, 4 mcg/mL in the U.S. market. Desmopressin acetate is a synthetic analogue of the natural pituitary hormone 8-arginine vasopressin (ADH), an antidiuretic hormone affecting renal water conservation.

North America is expected to be the most lucrative region in the vasopressin market, owing to presence of major key players such as Par Pharmaceutical, Pfizer Inc, Fresenius Kabi Canada, and Cumberland Pharmaceuticals.

Competitive Landscape:

Key players operating in the global vasopressin market include Par Pharmaceutical, Pfizer Inc., Novartis AG, Ferring Pharmaceuticals, Fresenius Kabi Canada, Astellas Pharma, Shanghai Soho-Yiming Pharmaceuticals, Endo International, Hybio Pharmaceutical, Hainan Zhonghe Pharmaceutical, and Cumberland Pharmaceuticals.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4646

Market Segmentation:

• Global Vasopressin Market, By Type:

  • Intravenous Injection

  • Intramuscular Injection

  • Subcutaneous Injection

• Global Vasopressin Market, By Application:

  • Anti-Diuretic Hormone Deficiency

  • Gastrointestinal Bleeding

  • Vasodilatory Shock

  • Ventricular Tachycardia & Fibrillation

• Global Vasopressin Market, By End User:

  • Hospital

  • Clinics

  • Others

• Global Vasopressin Market, By Region:

  • North America

• • • By Country

      • U.S.

      • Canada

• • Latin America

    • By Country

      • Brazil

      • Mexico

      • Argentina

      • Rest of Latin America

  • Europe

    • By Country

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

      • Russia

      • Rest of Europe

  • Asia Pacific

    • By Country

      • China

      • India

      • Japan

      • Australia

      • South Korea

      • ASEAN

      • Rest of Asia Pacific

  • Middle East

    • By Country

      • GCC

      • Israel

      • Rest of Middle East

  • Africa

    • By Region/Country

      • South Africa

      • Central Africa

      • North Africa

Related Market Intelligence Reports:

U.S. Injectable Compounding Pharmacy Market, by Molecule (Acetaminophen, Phenylephrine, Midazolam, Esmolol, Vancomycin, Epinephrine, Adenocaine, Fentanyl / Bupivacaine, Morphine, Amiodarone, Fentanyl, Heparin, Ketamine, Dextrose, Hydromorphone, Bupivacaine, Lidocaine, BKK (Bupivacaine, Ketorolac, Ketamine), RCK (Ropivacaine, Clonidine, Ketorolac), RKK (Ropivacaine, Ketorolac, Ketamine), Norepinephrine, Diltiazem, Vasopressin, and Others), by Packaging Type (Vials, Ampoules, Prefilled Syringes, and Others), and by Pharmacy Type (503A Pharmacies and 503B Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2021 – 2028

Dextrose Injection Market, By Product Type (5% Dextrose Injection, 10% Dextrose Injection, 50% Dextrose Injection, 70% Dextrose Injection, and Others), By Application (First-aid Treatment, Sports, Trophotherapy, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.

Follow Us: LinkedIn | Twitter

CONTACT: Mr. Shah Senior Client Partner – Business Development Coherent Market Insights Phone: US: +1-206-701-6702 UK: +44-020-8133-4027 Japan: +81-050-5539-1737 India: +91-848-285-0837 Email: sales@coherentmarketinsights.com Website: https://www.coherentmarketinsights.com